Cite
MLA Citation
S Robert et al.. “1ISG-001 Can rivaroxaban become cost saving compared with vitamin K antagonists in the treatment of patients with non-valvular atrial fibrillation in France?.” European journal of hospital pharmacy, vol. 27, n.d., p. A1. http://access.bl.uk/ark:/81055/vdc_100135177904.0x000006